You are here : Home / On the Air / Programming Guide

Programming Guide

Time Zone:  
12:00 AM Recent Changes in the Diagnosis and Management of Binge Eating Disorder cme segment CME
12:40 AM Update on Multiple Myeloma Clinical Trials with Proteasome Inhibition from the 55th ASH Annual Meeting cme segment CME
1:00 AM Expert Insight on Maximizing Novel Therapeutic Strategies for Moderate to Severe Plaque Psoriasis cme segment CME
1:20 AM Individualizing Treatment of Major Depressive Disorder: Balancing Efficacy with Tolerability cme segment CME
2:00 AM Preventing Blindness, Protecting Vision Health: A Focus on Open-Angle Glaucoma cme segment CME
2:40 AM Hypogonadism: A Conversation of the Pathophysiology, Etiology and Epidemiology with the NIH cme segment CME
3:00 AM The Basics of Melanoma Pathogenesis and Biology cme segment CME
3:40 AM Review of Guidelines for Use of Immunotherapies and Targeted Therapies in Melanoma cme segment CME
4:00 AM SGLT-2 Inhibitors: An Emerging Therapeutic Class in the Treatment of Diabetes — Part 2 of 2 cme segment CME
4:40 AM Rh Immune Globulin — Several Options, Which to Choose? cme segment CME
5:00 AM Optimizing Fetal Outcomes: The Evolving Role of Noninvasive Prenatal Screening cme segment CME
5:40 AM Cervical Cancer Screening: A Change in the Air? cme segment CME
6:00 AM Updates from ASCO 50th Annual Conference: New Horizons in the Management of Non-Small Cell Lung Cancer cme segment CME
6:20 AM Immunotherapy in Melanoma: How Melanoma Can Be Targeted to Immunotherapeutic Agents cme segment CME
7:00 AM Interleukin 2 (IL-2) in Melanoma: Anticipating and Managing Toxicities While Optimizing Outcomes cme segment CME
7:20 AM Prevention of Preterm Birth: The Critical Role of Progestogens cme segment CME
8:00 AM Acute Coronary Syndrome Cases in Care: An Expert Dialogue cme segment CME
8:40 AM New Advances in Targeted and Immune Therapies to Treat Patients with Melanoma cme segment CME
9:00 AM On the Frontlines of Asthma: Current and Emerging Therapeutic Strategies cme segment CME
9:40 AM Preventing Blindness, Protecting Vision Health: A Focus on Cataracts cme segment CME
10:00 AM Breast Health: Atypical Hyperplasia in the Continuum of Breast Cancer Risk Assessment cme segment CME
10:20 AM What is the Impact of New Immunotherapies on Survival in Metastatic Melanoma? cme segment CME
11:00 AM New Frontiers in Alzheimer?s Disease: Updates, Advancements, and Changing the Standard of Care cme segment CME
11:20 AM Preventing Blindness, Protecting Vision Health: A Focus on Age-Related Macular Degeneration cme segment CME
12:00 PM Recent Changes in the Diagnosis and Management of Binge Eating Disorder cme segment CME
12:40 PM Update on Multiple Myeloma Clinical Trials with Proteasome Inhibition from the 55th ASH Annual Meeting cme segment CME
1:00 PM Expert Insight on Maximizing Novel Therapeutic Strategies for Moderate to Severe Plaque Psoriasis cme segment CME
1:20 PM Individualizing Treatment of Major Depressive Disorder: Balancing Efficacy with Tolerability cme segment CME
2:00 PM Preventing Blindness, Protecting Vision Health: A Focus on Open-Angle Glaucoma cme segment CME
2:40 PM Hypogonadism: A Conversation of the Pathophysiology, Etiology and Epidemiology with the NIH cme segment CME
3:00 PM The Basics of Melanoma Pathogenesis and Biology cme segment CME
3:40 PM Review of Guidelines for Use of Immunotherapies and Targeted Therapies in Melanoma cme segment CME
4:00 PM SGLT-2 Inhibitors: An Emerging Therapeutic Class in the Treatment of Diabetes — Part 2 of 2 cme segment CME
4:40 PM Rh Immune Globulin — Several Options, Which to Choose? cme segment CME
5:00 PM Optimizing Fetal Outcomes: The Evolving Role of Noninvasive Prenatal Screening cme segment CME
5:40 PM Cervical Cancer Screening: A Change in the Air? cme segment CME
6:00 PM Updates from ASCO 50th Annual Conference: New Horizons in the Management of Non-Small Cell Lung Cancer cme segment CME
6:20 PM Immunotherapy in Melanoma: How Melanoma Can Be Targeted to Immunotherapeutic Agents cme segment CME
7:00 PM Interleukin 2 (IL-2) in Melanoma: Anticipating and Managing Toxicities While Optimizing Outcomes cme segment CME
7:20 PM Prevention of Preterm Birth: The Critical Role of Progestogens cme segment CME
8:00 PM Acute Coronary Syndrome Cases in Care: An Expert Dialogue cme segment CME
8:40 PM New Advances in Targeted and Immune Therapies to Treat Patients with Melanoma cme segment CME
9:00 PM On the Frontlines of Asthma: Current and Emerging Therapeutic Strategies cme segment CME
9:40 PM Preventing Blindness, Protecting Vision Health: A Focus on Cataracts cme segment CME
10:00 PM Breast Health: Atypical Hyperplasia in the Continuum of Breast Cancer Risk Assessment cme segment CME
10:20 PM What is the Impact of New Immunotherapies on Survival in Metastatic Melanoma? cme segment CME
11:00 PM New Frontiers in Alzheimer?s Disease: Updates, Advancements, and Changing the Standard of Care cme segment CME
11:20 PM Preventing Blindness, Protecting Vision Health: A Focus on Age-Related Macular Degeneration cme segment CME